Who
Anne Elizabeth Borgman
Director
Company insider
Files Form 4 as: Director, Curis; Director, NextCure; Chief Medical Officer, Sutro Biopharma.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 1 Oct 2021
- Last trade
- 7 Jul 2026
- Last filed
- 9 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Jul 2026filed 9 Jul 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $36K6,800 at $5.29 | filing |
| 7 Jul 2026filed 9 Jul 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $36K6,800 at $5.29 | filing |
| 18 Jun 2026filed 22 Jun 2026 | NXTC NextCureoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,340 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | NXTC NextCureoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,340 at $0.00 | filing |
| 20 Jun 2025filed 24 Jun 2025 | NXTC NextCureoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,700 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $45K14,400 at $3.13 | filing |
| 1 May 2025filed 5 May 2025 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —53,125 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,938 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | —53,125 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | —15,938 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code F | $26K24,709 at $1.07 | filing |
| 1 Mar 2025filed 4 Mar 2025 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,250 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | —11,250 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code F | $7,3474,621 at $1.59 | filing |
| 28 Feb 2025filed 4 Mar 2025 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —37,500 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | —37,500 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code F | $24K15,405 at $1.59 | filing |
| 28 Jan 2025filed 30 Jan 2025 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $5,0081,600 at $3.13 | filing |
| 20 Jun 2024filed 21 Jun 2024 | NXTC NextCureoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,700 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $49K4,250 at $11.62 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.